[go: up one dir, main page]

SI2861236T1 - Farmacevtski sestavek, ki vsebuje polimer, ki veže fosfat - Google Patents

Farmacevtski sestavek, ki vsebuje polimer, ki veže fosfat

Info

Publication number
SI2861236T1
SI2861236T1 SI201231657T SI201231657T SI2861236T1 SI 2861236 T1 SI2861236 T1 SI 2861236T1 SI 201231657 T SI201231657 T SI 201231657T SI 201231657 T SI201231657 T SI 201231657T SI 2861236 T1 SI2861236 T1 SI 2861236T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
composition containing
containing phosphate
binding polymer
phosphate binding
Prior art date
Application number
SI201231657T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Vasiliki Samara
Amalia Diakidou
Georgia Papanikolaou
Panagiotis Mparmpalexis
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of SI2861236T1 publication Critical patent/SI2861236T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201231657T 2012-06-15 2012-06-15 Farmacevtski sestavek, ki vsebuje polimer, ki veže fosfat SI2861236T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2012/002547 WO2013185789A1 (en) 2012-06-15 2012-06-15 Pharmaceutical composition containing phosphate binding polymer
EP12732788.0A EP2861236B1 (en) 2012-06-15 2012-06-15 Pharmaceutical composition containing phosphate binding polymer

Publications (1)

Publication Number Publication Date
SI2861236T1 true SI2861236T1 (sl) 2019-10-30

Family

ID=46465179

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231657T SI2861236T1 (sl) 2012-06-15 2012-06-15 Farmacevtski sestavek, ki vsebuje polimer, ki veže fosfat

Country Status (17)

Country Link
US (1) US9849147B2 (sl)
EP (1) EP2861236B1 (sl)
AU (1) AU2012382602B2 (sl)
CA (1) CA2876739C (sl)
CY (1) CY1122094T1 (sl)
DK (1) DK2861236T3 (sl)
ES (1) ES2748578T3 (sl)
HR (1) HRP20191669T1 (sl)
HU (1) HUE045603T2 (sl)
LT (1) LT2861236T (sl)
PL (1) PL2861236T3 (sl)
PT (1) PT2861236T (sl)
RS (1) RS59365B1 (sl)
SI (1) SI2861236T1 (sl)
SM (1) SMT201900555T1 (sl)
WO (1) WO2013185789A1 (sl)
ZA (1) ZA201500452B (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10245284B2 (en) * 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629013A (en) 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
EP0713389A4 (en) 1993-08-13 1997-05-21 Bayer Ag HYDROLYZED GELATIN USED AS A TASTE ENHANCER IN CHEWABLE TABLETS
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
MXPA04009617A (es) 2002-04-04 2005-01-11 Pfizer Prod Inc Comprimido masticable con sabor agradable.
WO2006016695A1 (ja) * 2004-08-10 2006-02-16 Ono Pharmaceutical Co., Ltd. Ep4アゴニストを含有してなる高カリウム血症の予防および/または治療剤
WO2007094779A1 (en) 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
EP2441779A1 (en) 2006-09-01 2012-04-18 USV Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
WO2009034540A1 (en) 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
MX337603B (es) * 2009-11-30 2016-03-10 Adare Pharmaceuticals Inc Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion.
WO2011135591A2 (en) * 2010-04-29 2011-11-03 Shasun Pharmaceuticals Limited Novel tablet composition of polyallylamine polymers

Also Published As

Publication number Publication date
HUE045603T2 (hu) 2020-01-28
WO2013185789A1 (en) 2013-12-19
US9849147B2 (en) 2017-12-26
ES2748578T3 (es) 2020-03-17
CA2876739C (en) 2019-02-26
SMT201900555T1 (it) 2019-11-13
EP2861236A1 (en) 2015-04-22
ZA201500452B (en) 2016-10-26
HRP20191669T1 (hr) 2019-12-13
LT2861236T (lt) 2019-09-25
PT2861236T (pt) 2019-10-28
AU2012382602A1 (en) 2015-01-22
CA2876739A1 (en) 2013-12-19
US20150182555A1 (en) 2015-07-02
AU2012382602B2 (en) 2016-02-11
CY1122094T1 (el) 2020-11-25
PL2861236T3 (pl) 2020-03-31
DK2861236T3 (da) 2019-10-14
RS59365B1 (sr) 2019-11-29
EP2861236B1 (en) 2019-07-17

Similar Documents

Publication Publication Date Title
ZA201501930B (en) Pharmaceutical composition
ZA201503594B (en) Pharmaceutical compositions
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
SG11201405575YA (en) Modified polymer compositions
IL266415A (en) Innovative pharmaceutical composition
SG11201501122WA (en) Solid pharmaceutical preparation containing levothyroxine
SG11201501661YA (en) Polymer composition
IL237146A0 (en) Pharmaceutical compound containing Rabamipide
ZA201502987B (en) Pharmaceutical composition
LT2638894T (lt) Farmacinė kompozicija, turinti fosfolipido
EP2851074A4 (en) ANALGETIC PHARMACEUTICAL COMPOSITION
EP2859885A4 (de) Antibakterielle pharmazeutische zusammensetzung
ZA201500452B (en) Pharmaceutical composition containing phosphate binding polymer
GB201211153D0 (en) Pharmaceutical compositions
ZA201406407B (en) Pharmaceutical formulation containing flupirtin
ZA201400751B (en) Pharmaceutical composition
ZA201209677B (en) Pharmaceutical composition comprising a phosphate binding polymer and method for the preparation thereof
GB201221130D0 (en) New pharmaceutical composition
GB201207701D0 (en) New pharmaceutical composition
GB201207628D0 (en) New pharmaceutical composition
AU2012904295A0 (en) Pharmaceutical composition
IL238075A0 (en) pharmaceutical preparations
GB201219234D0 (en) Pharmaceutical compositions
GB201213303D0 (en) Pharmaceutical compositions
GB201204810D0 (en) Pharmaceutical compositions